Acoustic molecular imaging and targeted drug delivery with perfluorocarbon nanoparticles

Gregory M. Lanza, Michael S. Hughes, Jon N. Marsh, Michael J. Scott, Huiying Zhang, Elizabeth K. Lacy, John S. Allen, Samuel A. Wickline

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review


Advances in molecular biology and cellular biochemistry are providing new opportunities for diagnostic medical imaging to "see" beyond the anatomical manifestations of disease to the earliest biochemical signatures of disease. Liquid perfluorocarbon nanoparticles provide inherent acoustic contrast when bound to targets, e.g., fibrin deposits in a thrombus, but unbound nanoparticles are undetectable. This nanoparticle platform may be further functionalized with paramagnetic metals, such as gadolinium, or radionuclides, with homing ligands, like anti-α vβ 3-integrins, and therapeutic agents. Acoustic imaging of densely distributed biomarkers, e.g., fibrin epitopes, is readily accommodated with fundamental imaging, but for sparse biomarkers, e.g., integrins, we have developed and implemented novel, nonlinear imaging techniques based upon information-theoretic receivers (i.e., thermodynamic receivers). These novel receivers allow sensitive direct imaging of contrast development.

Original languageEnglish
Title of host publication4th International Symposium on Therapeutic Ultrasound
Number of pages4
StatePublished - Mar 28 2005
Event4th International Symposium on Therapeutic Ultrasound - Kyoto, Japan
Duration: Sep 18 2004Sep 20 2004

Publication series

NameAIP Conference Proceedings
ISSN (Print)0094-243X
ISSN (Electronic)1551-7616


Conference4th International Symposium on Therapeutic Ultrasound


Dive into the research topics of 'Acoustic molecular imaging and targeted drug delivery with perfluorocarbon nanoparticles'. Together they form a unique fingerprint.

Cite this